Literature DB >> 30591535

Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.

Joan E Walter1, Marjolein A Heuvelmans1,2, Kevin Ten Haaf3, Rozemarijn Vliegenthart1,2, Carlijn M van der Aalst3, Uraujh Yousaf-Khan3, Peter M A van Ooijen1,2, Kristiaan Nackaerts4, Harry J M Groen5, Geertruida H De Bock6, Harry J de Koning3, Matthijs Oudkerk1.   

Abstract

BACKGROUND: The US guidelines recommend low-dose CT (LDCT) lung cancer screening for high-risk individuals. New solid nodules after baseline screening are common and have a high lung cancer probability. Currently, no evidence exists concerning the risk stratification of non-resolving new solid nodules at first LDCT screening after initial detection.
METHODS: In the Dutch-Belgian Randomized Lung Cancer Screening (NELSON) trial, 7295 participants underwent the second and 6922 participants the third screening round. We included participants with solid nodules that were registered as new or <15 mm³ (study detection limit) at previous screens and received additional screening after initial detection, thereby excluding high-risk nodules according to the NELSON management protocol (nodules ≥500 mm3).
RESULTS: Overall, 680 participants with 1020 low-risk and intermediate-risk new solid nodules were included. A total of 562 (55%) new solid nodules were resolving, leaving 356 (52%) participants with a non-resolving new solid nodule, of whom 25 (7%) were diagnosed with lung cancer. At first screening after initial detection, volume doubling time (VDT), volume, and VDT combined with a predefined ≥200 mm3 volume cut-off had high discrimination for lung cancer (VDT, area under the curve (AUC): 0.913; volume, AUC: 0.875; VDT and ≥200 mm3 combination, AUC: 0.939). Classifying a new solid nodule with either ≤590 days VDT or ≥200 mm3 volume positive provided 100% sensitivity, 84% specificity and 27% positive predictive value for lung cancer.
CONCLUSIONS: More than half of new low-risk and intermediate-risk solid nodules in LDCT lung cancer screening resolve. At follow-up, growth assessment potentially combined with a volume limit can be used for risk stratification. TRIAL REGISTRATION NUMBER: ISRCTN63545820; pre-results. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  lung cancer

Mesh:

Year:  2018        PMID: 30591535     DOI: 10.1136/thoraxjnl-2018-212152

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  5 in total

Review 1.  Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe.

Authors:  Giulia Veronesi; David R Baldwin; Claudia I Henschke; Simone Ghislandi; Sergio Iavicoli; Matthijs Oudkerk; Harry J De Koning; Joseph Shemesh; John K Field; Javier J Zulueta; Denis Horgan; Lucia Fiestas Navarrete; Maurizio Valentino Infante; Pierluigi Novellis; Rachael L Murray; Nir Peled; Cristiano Rampinelli; Gaetano Rocco; Witold Rzyman; Giorgio Vittorio Scagliotti; Martin C Tammemagi; Luca Bertolaccini; Natthaya Triphuridet; Rowena Yip; Alexia Rossi; Suresh Senan; Giuseppe Ferrante; Kate Brain; Carlijn van der Aalst; Lorenzo Bonomo; Dario Consonni; Jan P Van Meerbeeck; Patrick Maisonneuve; Silvia Novello; Anand Devaraj; Zaigham Saghir; Giuseppe Pelosi
Journal:  Cancers (Basel)       Date:  2020-06-24       Impact factor: 6.639

2.  Deep convolutional neural networks for multiplanar lung nodule detection: Improvement in small nodule identification.

Authors:  Sunyi Zheng; Ludo J Cornelissen; Xiaonan Cui; Xueping Jing; Raymond N J Veldhuis; Matthijs Oudkerk; Peter M A van Ooijen
Journal:  Med Phys       Date:  2020-12-30       Impact factor: 4.071

3.  The growth feature and its diagnostic value for benign and malignant pulmonary nodules met in routine clinical practice.

Authors:  Rui Zhang; Panwen Tian; Zhixin Qiu; Yiying Liang; Weimin Li
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

Review 4.  Implementation of lung cancer screening in Europe: challenges and potential solutions: summary of a multidisciplinary roundtable discussion.

Authors:  John K Field; Harry deKoning; Mattijs Oudkerk; Sadia Anwar; James Mulshine; Ugo Pastorino; Wilfried Eberhardt; Helmut Prosch
Journal:  ESMO Open       Date:  2019-10-13

5.  Defining growth in small pulmonary nodules using volumetry: results from a "coffee-break" CT study and implications for current nodule management guidelines.

Authors:  Emily C Bartlett; Samuel V Kemp; Bhavin Rawal; Anand Devaraj
Journal:  Eur Radiol       Date:  2021-09-27       Impact factor: 5.315

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.